SIT Graduate Institute/SIT Study Abroad

SIT Digital Collections
Independent Study Project (ISP) Collection

SIT Study Abroad

Spring 2009

Mandatory Measles Vaccination Program: Is There
a Place for one in Switzerland?
Anne Rushman
SIT Study Abroad

Follow this and additional works at: https://digitalcollections.sit.edu/isp_collection
Part of the Community Health and Preventive Medicine Commons
Recommended Citation
Rushman, Anne, "Mandatory Measles Vaccination Program: Is There a Place for one in Switzerland?" (2009). Independent Study Project
(ISP) Collection. 690.
https://digitalcollections.sit.edu/isp_collection/690

This Unpublished Paper is brought to you for free and open access by the SIT Study Abroad at SIT Digital Collections. It has been accepted for
inclusion in Independent Study Project (ISP) Collection by an authorized administrator of SIT Digital Collections. For more information, please
contact digitalcollections@sit.edu.

Mandatory Measles Vaccination Program:
Is there a place for one in Switzerland?
By Anne Rushman
Spring 2009

Development Studies and Public Health
Dr. Earl Noelte
Washington University in St Louis
College of Arts & Sciences
Political Science

Table of Contents
Copyright Permission
Abstract
Acknowledgements
Preface
Paper
Introduction
Methodology
Swiss Health Care System
Medical Perspectives
Other Country Profiles
Analysis
Swiss Health Care System
Medical Perspectives
Other Country Profiles
Policy Recommendation
Proposed Solutions
Next Steps
Conclusion
Bibliography
Work Journal
Chronology
Advisor Meetings
Interviews
Human Resource List
Works Site
Interactive Research Hour Log

3
3
4
5
6
9
9
11
13
18
18
19
20
23
26
30
31
32
34
34
40
41
45
48
49

2

Copyright Permission
The author hereby does grant the School for International Training the permission to
electronically reproduce and transmit this document to students, alumni, staff, and faculty of
the World Learning Community.
The author hereby does not grant the School for International Training the permission to
electronically reproduce and transmit this document to the public via the World Wide Web
or other electronic means.
The author herby does not grant the School for International Training the permission to
reproduce this document to the public in print format.
Anne Rushman

April 23, 2009

Abstract:
Vaccines are commonly cited as one of the most effective public health measures – they are
not only effective, but they are cost efficient as well. Vaccines are implemented in both
developed and developing settings, but the focus on increasing vaccination coverage typically
is centered on the developing world. While it is important to continue to increase
vaccination rates in developing countries it is also important to maintain or reach herd
immunity in developed countries. Switzerland, and the recent measles outbreak there, serves
as an example of the importance of placing a focus on [measles] vaccination in developed
countries. In the wake of this most recent measles outbreak, the discussion of making the
measles vaccine mandatory had commenced. This paper explores the possibility of making
the measles vaccination mandatory specific to Switzerland’s unique health care system while
taking into account the medical opinion from both the alternative and contemporary
perspective. It also explores the state of measles vaccine coverage and programs in other
developed nations. In conclusion a mandatory measles vaccine program in Switzerland is
recommended, but not without hesitation to how it may be adapted in the Swiss health
system.
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Preface
The investigation of this topic began as a curiosity from the measles outbreak in the canton
of Vaud, Switzerland in early 2009. As I began to gain a deeper knowledge of the subject of
measles and measles vaccination in this community I saw the potential it held as a topic to
explore my interests in the juncture of public policy and public health. As I approached the
topic of measles vaccination from not only a public health perspective but also from that of
political and ethical perspective I was able to make an analysis of potential changes in the
health policy of Switzerland for a mandatory measles vaccination. The following paper
details my efforts to explore the potential of a mandatory measles vaccine in Switzerland.
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Mandatory Measles Vaccination Program:
Is there a place for one in Switzerland?
Introduction
Vaccines are widely touted as one of the most effective public health measures.1
They are cost effective, becoming easier to transport and deliver, and have high efficacy rates
when delivered to high rates of the population. The smallpox virus has been eradicated
worldwide due to the development and then successful global implementation of a smallpox
vaccine. This is the most drastic result of a vaccination, eradication, but there are many
other successes we have seen from vaccines. Childhood deaths and disease burden has been
lowered due to vaccinations. While it is a wide spread belief that vaccines are an effective
tool in combating vaccine preventable diseases and are a promising venue for research in
disease prevention in the future there is an increasing backlash against the vaccine
movement.
While the focus in vaccine delivery has been on the developing world for quite some
time the developed world in many areas has gone backwards in vaccine coverage rates and a
resurgence of previously almost non-existent diseases is on the rise.

The focus when

studying vaccines has been to the developing world, how to make transportation to remote
areas possible, training personnel to administer vaccines, simplifying the vaccine delivery
process and achieving herd immunity.

While the focus on the developing world is

important, the developed world has its own set of problems that must be addressed as well.
This calls for a new look to vaccination in developed countries and perhaps a new approach
to promoting vaccination.

1

Feudtner et al 2001 pg 1158
6

The focus on developing countries is important, and must concurrently continue.
Developing countries have a low vaccine coverage rate, which leads to high disease
incidence. The effects of this are seen at a greater extent because in these locations they are
also suffering from poor health infrastructure and care systems.

This makes the

consequences of vaccine preventable diseases more serious and a higher percentage of
deaths occur because of them. Because the results of not being vaccinated are much more
grave in developing countries they receive the bulk of attention when discussing vaccine
preventable diseases. Since developing countries are the focus of research and the US
mandatory vaccination program is still quite effective I assumed that vaccine preventable
diseases were not of great concern or occurrence in developed countries.
Upon my arrival in Switzerland this belief was quickly set aside as newspaper
headlines daily depicted the measles outbreak in the canton of Vaud, where I was living.
This contradiction to my previous thoughts and knowledge sparked my interest and
encouraged me to investigate and research why Switzerland, which is typically thought of as
a very healthy nation, is not successfully implementing one of the most effective public
health measures. There is no excuse for not maintaining high levels of vaccination coverage
and low disease incidence in developed countries, as there is a highly effective vaccine for
measles. The health and economic consequences of vaccine preventable diseases are high,
and avoidable.
This original curiosity led me to investigate the current situation in Switzerland
surrounding measles and the measles vaccination. This went beyond just looking at measles
and vaccination, but to look deeper into the various levels of the issue and the range of
stakeholders in measles vaccination.

7

An important aspect of my research, to develop not only the context but also the
possibilities for the future, was the Swiss health care system. This entailed looking at how
the Swiss health care system is governed, which is a very different system that the United
States. Power is very decentralized in all aspects of Swiss government, including the health
care system. Each of the 26 cantons are in charge of their own health care infrastructure.
While one can argue that this system seems to work for the Swiss, it makes creating and
implementing policy very difficult on a national level. This is key when trying to eliminate
highly contagious diseases such as measles in a globalized world full of human movement
both internationally and nationally.
I then took to looking at measles vaccinations through an ethical perspective. This is
an important aspect to regard as I began to look at the prospect of a mandatory measles
vaccination program in Switzerland. The decisions that are made as to whether it is more
important to maintain individual autonomy and ones right to chose their health outcomes, or
regulate individual choice for the health of a community. This dilemma of which rights, that
of individual autonomy or community health, is superior is at the center of discussions about
measles vaccinations and whether they should by mandatory.
Switzerland’s unique governing system and low vaccination rates led to a curious
investigation of how a mandatory vaccination program might fit into not only the health care
system in Switzerland, but also in the society. My research took me through an analysis of
the Swiss health system, other developed countries vaccination programs, the medical, both
contemporary and alternative, perspective of measles, and the school as an integral part of
the health system. The combination of this research brought me to the conclusion that there
is a place for a mandatory vaccination program in Switzerland, but the development and
implementation of such a program would have to take into special consideration the
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situation in Switzerland. It would require changes in many levels and organizations of Swiss
society. Because of the broad range of changes that would need to occur support from
many levels would be critical – from the government both politically and economically, the
community, the health sector and schools. Since the Swiss government is so decentralized it
is perhaps far fetched to believe that changes could be made on a nation-wide level to
implement a mandatory vaccination program. Though it would elongate the process, and
take longer to see results, the most logical and plausible solution would be for a bottom up
approach, some of the more progressive cantons would implement a mandatory vaccination
program that would eventually be implemented in all 26 cantons.
Methodology
To be able to come to an educated and logical conclusion on the potential role of a
mandatory vaccination program it was essential to examine the situation from a variety of
perspectives, institutions and parts of Swiss society. Beyond examining the situation in
Switzerland I found it invaluable to become familiar with how other developed countries,
similar to Switzerland had successfully or unsuccessfully tried to increase measles vaccination
coverage. By looking at the issue from a variety of perspectives both from within and
outside of Switzerland I was able to evaluate the pros and cons of making the measles
vaccination mandatory and some of the potential barriers to making measles vaccination
mandatory in Switzerland.
Swiss Health Care System
The first facet to discuss is Switzerland – its government and its health system.
While this wasn’t my initial avenue of research, I find it an important underlying factor when
examining the other perspectives. As mentioned previously the Swiss government is very

9

decentralized, since the adaptation of a federal constitution in 1848 the majority of the
responsibility for health was put to the cantons, so the cantons have separately formed the
Swiss health system since then. 2 Switzerland spends more as a share of GNP than any other
OECD country, other than Germany and the US, but has a much lower estimated
vaccination coverage for measles. It is estimated that there is around 82% coverage for the
measles vaccination in Switzerland where as the OECD average is 91%.

3

The cantons are

widely realized at those with the responsibility to develop and implement health-policy, by
leaving the responsibility up to the 26 individual cantons has led to 26 slightly different
health systems, all under the common thought of the Swiss health system.4
Looking more specifically at the health system in Switzerland requires examining
each canton as an individual system. While regionally Switzerland varies to a greater extent
the farther apart the cantons are, for this introductory study the examination took place of
the canton of Geneva and the canton of Vaud, neighboring cantons in the French speaking
area of Switzerland. When looking at the canton’s of Geneva and Vaud I looked specifically
at how vaccines were distributed and how this was managed and governed. Focusing on
these two specific cantons was not only important as they serve as leaders in the realm of
vaccinations, but also these two cantons allowed me the greatest opportunity to interact with
professionals in their respective health systems. These are two of the cantons with the
highest vaccination coverage rates in Switzerland.5 The way that these two cantons choose to
manage their health care is very different for vaccinations. Both cantons combine the
education system and the health system, but for Geneva the health system is managed by the

2
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education system, whereas in Vaud the education system and the health system manage side
by side.6 The biggest effect this has is on what type of emphasis is placed on vaccination
programs and ensuring that prevention efforts are a priority.
Medical Perspectives
With the focus of the Swiss health system as a constant background to the research
and investigation into the medical perspective was more insightful. I was able to apply their
thoughts to the specific setting of Switzerland, and more specifically to the cantons of
Geneva and Vaud. This was also an important research aspect as it was where I was able to
be most interactive in my setting. I was able to not only discuss the medical and public
health benefits but also discuss them specific to a Switzerland context.
An earlier observation and investigation of the Swiss health culture led me to
investigate the large following and emphasis on alternative and homeopathic medicine. As
this is a critical part on many individuals health care I reasoned that this alternative health
care sector would also play a valuable role in vaccination coverage. Thus I investigated not
only contemporary medicine’s view and practice with measles vaccination, but also paid
close attention to how measles vaccination was dealt with in alternative or homeopathic
medicine practices.
From a contemporary medical perspective the measles vaccine is preferable. This
conclusion is arrived at from a risk-benefit analysis. The risk you take on from receiving the
measles vaccine are minimal, especially when compared to the benefits of immunizing
yourself against measles and the potential complications from contracting measles.7 Another
aspect to look at is not only the individual’s health, but also the health of the community or
6
7

Duppereux, Olivier 14.4.2009
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population.

When making this analysis for the benefit of the health benefits for an

individual and the benefits for the community there are substantial benefits for both. The
individual protects himself or herself when vaccinating against measles, and with a higher
number of individuals vaccinated it protects the entire community. This calculation of
benefits becomes complicated though because herd immunity, the level that must be
obtained to protect the entire population, is below 100%. For measles, herd immunity is
reached at a level of 95% vaccination coverage since it is a highly contagious disease. Since a
community can be protected without 100% measles vaccine coverage this allows for free
riders, and as an increasing number of people rely on the rest of the community to keep
them measles free herd immunity is not established thus leaving the population at risk of
infection.
For homeopathic medicine there is not a clear answer for either pro or anti measles
vaccination. The opinion, and intensity of the opinion varies between homeopathic doctors
and from patient to patient. The homeopathic doctor that I was able to interact with
focused on a more holistic view of his patients, which led to a varied analysis for each
patient. It is more important to look at the health of patients from all angles, and for some it
will be more beneficial to be vaccinated and for others the risks associated with vaccinating
are not worth it. 8 The calculation of risk-benefit from the homeopathic perspective is very
different, thus the analysis has a different conclusion, because they see the risks and benefits
reaching beyond just getting measles or not, or getting side effects from the vaccine or not,
but extending to the mental well being of a patient and their philosophical beliefs.
When discussing the measles vaccine with Dr. Loutan, and how he approaches the
topic and deals with it in his practice, he took me through a few scenarios and criteria to
8

Loutan 9.4.2009
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consider. He approaches it as a discussion with the patient, looking to see first whether they
are initially either for or against vaccinating their children, as is normally the case with
measles vaccination. He never just takes a “no” answer to the measles vaccine, as he sees it
as very important to discuss the reasoning of why one chooses not to vaccinate. He wants
to make sure the patient has thought it through and that both parents are comfortable with
the decisions being made. This is important for the well being of the child so that if the
child does contract measles the parents will treat it in an appropriate manner as a team of
parents rather than divided.
Case Studies
Having an understanding of the Swiss health system and the knowledge from both
the contemporary and alternative medicinal viewpoints I investigated what other types of
policies and actions other nations have developed and implemented. I focused on other
developed nations that have established health care systems that used a variety of methods
and programs – both mandatory and voluntary. This was a more distant type of research as
I was researching vaccine programs from settings I was not present in. The reading of
reports on these programs was valuable in considering what options were available for
Switzerland and what could potentially work.
Australia – Financial Incentives
The country of Australia implemented a policy with the hope of increasing
vaccination coverage through financial incentives in 1998. The goal was to provide financial
incentives to parents to encourage age appropriate vaccination.9 One type of financial
payment parents who appropriately vaccinated was a payment to the parents and the other
9
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type of financial incentive was linked to childcare, if children were appropriately vaccinated
and the parents worked payments were made to aid in affording certain types of childcare.
This was the first study to examine whether the prospect of financial payments made an
impact on a parents’ decision to immunize. Their findings concluded that where parents
were informed about the incentive payments there was a significant association with a child’s
immunization status.10
Finland – Strong Elimination Program, is it sustainable?
Finland began a strong elimination campaign of measles, mumps and rubella (MMR)
in 1982 – and successfully eliminating measles and mumps in the late 1990’s, now though
they are seeing perhaps a reversal with new cases popping up.11 The program focused on
ensuring that each child received two doses of the MMR vaccine. The choice to vaccinate
was entirely voluntary, and the vaccines and delivery of them were free. The success in
eliminating measles, mumps and rubella they accredit to the efficacy of the vaccine, an
already established primary health system, motivated personnel, a well-organized and guided
project, and the small population of Finland.12 There is concern though that as measles has
been eliminated for over 10 years it has been observed that antibody levels are lowering as
well as the fact that vaccination levels are lowering.
US - Trial and Error to achieve elimination
The United States aimed to reduce and then eliminate measles from the introduction
of the measles vaccine in 1963. 13 It took the United States many years, and many changes in
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their strategy to eliminate measles.

One major concern with eliminating measles is

maintaining high vaccination coverage, the US did not account for the maintaining of the
high coverage and dropped funding for the measles vaccination just six years after the
vaccine was introduced, and fewer than half the states had any type of immunization
requirements.14 In the early 1970’s the focus of measles vaccination was lost and not
surprisingly there was a rise in the incidence of measles infection.
This increase in measles cases instigated a new childhood immunization program
that focused on increasing government support at both the state and federal levels.15 There
was initial success in increasing vaccination coverage rates and more lofty goals were
established – a date was set for eliminating measles.

School entry immunization

requirements were set; this helped in regulating and enforcing vaccination and also with
documentation and record keeping. There has been frequent discussions surrounding the
legality and ethical dilemma of mandating vaccinations but, “the United States Supreme
Court has upheld the right to pass mandatory immunization laws on two different
occasions.”16 Though there was an increase in measles vaccination coverage, there was also a
continued incidence of measles that led to studies about the effectiveness of the vaccine. It
was concluded that a second dose of the measles vaccine would improve coverage and
protection from measles, this led to a recommendation for a second dose of the measles
vaccination for school aged children.
After a measles outbreak at the end of the 1980’s there again was a refocusing and
change in strategy to work towards measles elimination. This was realized through an
increase in funding and an improved childhood immunization program that included two
14
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doses of the measles vaccine, as well as increased surveillance and a formal reporting and
response strategy.17 Though it took the US several decades to reach a state with measles
here they can call themselves measles free the governmental and financial support to the goal
as well as using the school system as a way to enforce and track vaccination records were the
factors that led to their success. Having elementary school vaccination laws has been proven
in recent years to increase vaccination rates and decrease the incidence of vaccine
preventable diseases.18
UK – A battle with public response to the link between autism and vaccination
In 1998 a study was released by researchers in the UK about a possible link between
autism and vaccination. This report was picked up by the media and became well known to
the public, which took into question whether this added potential risk made vaccination a
viable choice. It did not take long for the measles vaccination coverage rates to drop,
bringing communities below herd immunity and in time, by 2004, there were large outbreaks
occurring throughout the UK.19 Not only did this report cause parents to question whether
the measles vaccination caused autism, but a recent study in New Zealand revealed that
“one-third of health providers in New Zealand still had significant uncertainty about
whether MMR caused autism.”20 The consequences of this report were extensive and shook
the health system in the UK for how to handle the report that the MMR vaccine caused
autism.
The considerations that were taken when trying to boost vaccination coverage rates
after the damage done from the report linking the measles vaccine and autism are similar
17
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contemplations taken into account when trying to reach herd immunity in any situation.
They deemed it important to maintain parents’ autonomy in the decision to vaccinate or not,
be conscious of the various sides of the debate and acknowledge the concerns surrounding
them, and be able to communicate effectively your message to the public.21
Germany – What happens when measles vaccination is not a priority
Germany does not have a mandatory vaccination program, but they do document
vaccination status at school entry.22 A survey of measles vaccination coverage was analyzed
after an outbreak in 2006, the high cost, both economically and otherwise on a society and
health system, of responding to a measles outbreak is noted as a primary concern for
increasing measles vaccination. Since vaccination is not mandatory in Germany the records
that are gathered at school entry are voluntary and are thought to be skewed numbers as
those who have been vaccinated are more likely to present their vaccination record than
those who have not been vaccinated.23 The survey after the outbreak suggested that
forgetfulness and rejection were the two most common reasons for a child not to be
vaccinated. The situation in Germany is worrisome as it extends beyond having outbreaks,
but Germany does not have a plan to increase immunization coverage.24
It is recognized that there is no plan in place and that this does not put Germany, or
Europe in good standing for meeting the goal of eliminating measles by 2010.

The

researchers in this post outbreak survey suggest that the “Introduction of mandatory
vaccination or the imposition of sanctions on families with unvaccinated children is likely to

21

Burgess et al 2006 3926
Wichmann et al 2009 108
23
Wichmann et al. 2009 pg 112
24
Wichmann et al. 2009 pg 112
22

17

be legally and culturally accepted in Germany.”25 They also suggest several other alternatives
to increase vaccination rates, and perhaps quicker; requiring vaccination for entry into day
care, incentive payments to physicians and or families, implementing catch-up vaccination
programs, and an increase in governmental and political support.
Analysis
Swiss Health Care System
The decentralization of the Swiss health system poses a problem for putting forward
a united front in response to health issues. Furthermore the Swiss government has “never
defined explicitly the overall objectives of the health system or defined standards and
measures to assess whether these goals are being achieved.”26 This shows that the Swiss
health care system poses problems at each level of policy development and implementation.
This decentralization of the health system already poses problems with the existing
framework in place with regards to measles. The most recent measles outbreak in
Switzerland initiated a response from the federal government; they sent a plan of action for
reporting and containing cases of measles within their cantons. Though this came from the
federal government, it did not hold much weight with individual cantons as only a few
cantons followed these guidelines.27 Another recent vaccination policy that the federal
government attempted to influence from their perspective was the HPV vaccine. They
recommended to each canton that they develop an HPV vaccine program to educate their
communities and make it available.28 This resulted in many different types of programs,
some not doing anything, with varying levels of success and no federal oversight. The
25
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formation of the Swiss health care system is best suited for a bottom up approach where
cantons take control of issues, but to achieve national success and health responsibility and
action from the federal government is necessary.
Medical Perspectives
The contemporary and alternative medical communities have many similarities when
it comes to measles vaccination – they both want what is best for their patients and feel that
measles vaccination can be an avenue to accomplish this. This conclusion is arrived at
differently, and in the case of alternative medicine it is not so generally applied. The
important calculation and analysis that comes from the medical perspective is the riskbenefit analysis.
The risk-benefit analysis that is calculated from the contemporary medical
perspective is straightforward, where as the alternative approach is holistic in nature so it
becomes much more complex. In the contemporary analysis the only risks and benefits that
are acknowledged are those directly associated with the measles vaccine or with contracting
measles. This analysis one could argue is more accurate, and I for one believe it is a
satisfactory evaluation to generalize whether the measles vaccine is an appropriate public
health measure for both an individual as well as for the community. In the risk-benefit
analysis of the measles vaccine from the contemporary perspective the vaccine is beneficial
to both the individual and the community.
When the alternative medicine community conducts their risk-benefit analysis of the
measles vaccine it is necessary to conduct this on an individual basis. They look primarily at
the risks and benefits of the individual, not taking into account the community for this
calculation. While their concerns for an individual’s health are valid, the emphasis on the
consequences beyond the measles disease are perhaps thinking too widely. Also, the benefits
19

of vaccination, including the measles vaccine are for the greater good of a community and
these considerations deserve a large part of the risk-benefits analysis.
Case Studies
When looking to apply the lessons learned from these other case studies to
Switzerland it is difficult so broadly assume that practices can be applied from one scenario
to the next, but it is helpful to analyze what worked and didn’t work in other contexts and
then evaluate as best as possible if it can be translated to the Swiss system. Starting with the
financial incentive program that was implemented in Australia. My first reaction to this type
of program was confusion, I was confused as to how paying people to perform certain
medical practices was ethical. This seemed to be a breech of ethical medical practices, as it
put pressure on individuals to act in a certain way and obtain certain medical interventions.
It also places more pressure on individuals in economically unstable situations.
While I assumed that using incentive payments to increase vaccination coverage rates
would not be effective in developed countries where payments would need to be quite high
to have an influence on parents, but the research in Australia showed that the knowledge of
the payments increased vaccination rates in children. In discussions with Dr. Duperrex we
discussed the difference in providing incentive payments to patients versus payments to
physicians. Dr. Duperrex felt the ethical dilemmas intertwined in incentive payments were
difficult, but that the they can be effective and ethical for patients, but there is more of a
gray area in providing incentive payments to physicians.29 Dr. Seigrest also felt that though it

29
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was natural to have the immediate reaction be to question the ethics of incentives, they can
be useful as a motivation factor.30
Both the experiences of the US and Finland emphasized the need for political and
economic support for a successful elimination of measles. I have always felt that the
government plays an essential role in carrying out health policy and achieving health care
goals. These examples emphasized that the role of the government is crucial in achieving
higher measles vaccination coverage. While both governments eliminated measles through
their respective programs they did so in very different ways.
Finland was successful with a voluntary program that emphasized education and
utilization of their existing health care structure to achieve elimination. Though Finland
attributes it success to many factors that it shares with Switzerland – small population, health
care at a community level and strong base of health care workers – the success of their
efforts are coming into limbo.31 Though Finland was able to reach a level of vaccination that
eliminated measles the voluntary status of their program is making it difficult to sustain high
measles vaccination coverage. Though their strong support from their government made it
possible to eliminate measles, it seems that their policy did not take into account maintaining
measles elimination status.
The United States on the other hand eliminated measles, and is continuing to exhibit
measles vaccination coverage at levels that will maintain elimination. Though the United
States took three decades to eliminate measles, it is also a perfect example of the importance
of government support. The United States went through many phases of their elimination
strategy, and had many downfalls to their early successes. Anytime the government removed

30
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measles vaccination/elimination from the agenda and dropped funding of vaccination
programs, vaccination coverage would lower and measles incidence would rise.32 This
emphasized the importance of continued support for a government, not only in terms of
policy but also in economic support.
The UK and Germany are examples of countries that have, like Switzerland,
struggled to get measles incidence and vaccination under control. The lessons learned from
the case of the UK is the importance of communication and trust and from Germany the
importance of making measles a priority by putting it on the agenda and having an action
plan for it. In the UK the study linking autism and vaccination shook the entire vaccination
system in the UK, and around the world. It raised skepticism to the benefit and risk balance
as well as brought into question whether doctors were considering an individual’s health.
This can be a lesson learned that forming a trusting relationship with patients, and
acknowledging concerns and risks of vaccination are much more helpful than ignoring that
the concerns are there. Though the risk between autism and vaccination have been disputed
and the measles vaccine has proven effective skepticism still exists, even in Switzerland.
When discussing with Dr. Duperrex current issues with vaccine delivery in Vaud he cited the
hesitation and disapproving recommendations from nurses.33 He mentioned the problems
that they are having with nurses discouraging vaccination because of their own personal
beliefs. This is a difficult issue to identify, and resolve, but is a real concern.
In Germany the lack of acknowledgement, prioritization or action surrounding
measles and measles vaccination has meant frequent outbreaks of the disease putting strains
on the health and education systems. This has to be a warning to Switzerland that a lack of a

32
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national action on measles and the measles vaccine will only lead to more frequent
outbreaks, higher costs, and a less productive society.
Policy Recommendation
When looking to develop and implement a new health policy, or more specifically in
this case an immunization policy, it is important to look at a variety of categories. Using the
approach from Feudtner and Marcuse the analysis can be broken down into three main
considerations.34 These three focus areas are the disease, the vaccine, and the effects of the
policy.
Starting off with the disease – measles – it must be looked at through two
viewpoints, the individual and the community. This is where a lot of the previous discussion
on risk-benefit analysis becomes relevant. In terms of the individual and the disease,
measles, you look at the likelihood of the individual getting measles, and then the subsequent
consequences. Measles is a highly contagious disease, so without vaccination in a population
where measles is present an individual stands a large risk of contracting it. Once an
individual contracts measles there is not a treatment for it, which strongly supports a
prevention perspective for it.35 While current medical advancements that are widely available
in the developed world make fatality from measles not very common there are still
complications, such as encephalitis, that can occur because of measles. When examining
measles and the community it is important again to note it’s highly contagious nature. Once
measles is present in a community it is likely to spread throughout the un-immunized
population, it is estimated that in an un-immunized population 90-100% of the individuals

34
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will become infected if measles is introduced.36 Another important consideration for the
community in relation to measles is the cost, and examining the cost of infection. The cost
of measles infection varies greatly depending on side effects and whether hospitalization is
needed, but when examining the costs it is important to remember that measles is a vaccine
preventable disease, and through vaccination these costs can be avoided. For an estimate
and example of the cost of the measles vaccination a recent study of the 2006 measles
outbreak in Germany reveals that the average cost of a measles case in that outbreak was
€520 for each of the 614 cases.37
Now moving onto the second consideration of the vaccination itself, here it is
important to look at how effective the vaccine is, what level is needed for herd immunity,
the possible side-effects from the vaccine, the possibility of eliminating measles, and the cost
of vaccination.

The measles vaccine is highly effective; if an individual receives the

recommended two doses of the vaccine it is about 99.4% effective.38 Since measles is very
contagious it requires a large coverage rate, around 95%, to reach herd immunity and be able
to eliminate measles.39 The side effects from the measles vaccine are not common and
usually are limited to a rash or the like. A report in the late 90’s linking autism with
vaccination was a major set back until the results of the study were disputed in 2004, but was
important in showing that a community has its limits in the amount of risk they will take on
to vaccinate. Eliminating measles worldwide will be difficult, if even possible, but it has
already been eliminated in some regions/countries. The cost of the measles vaccine is low,
and cost is not prohibitive in developed countries such as Switzerland. Previous cost-benefit
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analysis of the measles vaccine has shown that the measles vaccine “saves more lives per unit
cost than any other health intervention.”40
The final consideration to examine is the policy related issues, here it is important to
look at individual autonomy in health choices, distribution of benefits and burden, the health
of a community. The overarching goal of this part of the analysis is balancing the rights and
health of an individual with the rights and health of a community. Individual autonomy is an
important right and must be considered when considering forcing a type of medical
intervention. This is why it is important to look at community opinions of a mandatory
vaccination program and the amount of force that would be required to enforce. It is
estimated that about 80% of the population freely chooses to vaccinate without hesitation,
5% adamantly opposes vaccination for religious or philosophical reasons and 15% of the
population is neither for nor against vaccination.41 These statistics show a fairly high
consensus for vaccination and that there is a very limited population that would feel any type
of force in implementing a mandatory vaccination program.

The benefits felt by a

mandatory vaccination program would be on both an individual level, as individuals would
be protected, but also at a community level as it would facilitate herd immunity being
reached. The burden of a mandatory measles vaccination program would placed on those
who experienced any type of side effect from the disease and on a much broader level the
burden of paying for a mandatory vaccination program would be felt by a larger part of the
population. This balance of rights of an individual and a community and benefits and
burdens show that a mandatory measles vaccination program in Switzerland would be
beneficial to individuals and the community.
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Overall, through the examination of these three main considerations of an
immunization policy for measles – the disease, the vaccine, and the policy, show that measles
is a well-suited disease to implement a mandatory vaccination program in Switzerland. It’s a
highly contagious disease that can be effectively controlled through the preventative use of a
vaccine, which is also cost effective. A few individuals would absorb the burden from the
side effects of the measles vaccine, which are low, but would still unfortunately be present. It
would be important for a support system to be available to absorb some of these burdens so
they were spread out rather than focused in on a few individuals.
This thoughtful and thorough analysis is important to practice. This is larger than
just the debate on a mandatory measles vaccination program, but extends to other existing
vaccinations and more importantly will play an increasingly important role in the future as
new vaccinations arise. As new vaccinations reach the market and are recommended, this
increases the number of vaccinations an individual is faced with. Now with recommended
childhood vaccines reaching double digits, “immunization fatigue” is not uncommon.42 This
raises the question of whether immunization fatigue is a valid concern or issue, and if so how
do we prioritize vaccination recommendation. This is where this careful three-part analysis
has the capability to play a large role in the future of vaccine recommendation.
Proposed Solutions – A way to make a mandatory measles vaccination program work in Switzerland
One important step that can be taken at the federal level is the financing of the
measles vaccination. Though the cantons are individually in charge of health-care the federal
government is responsible for the insurance system.43 Since the federal government is in
charge of the insurance system they have the ability to change how insurance coverage
42
43

Seigrest 14.4.2009
OECD Reviews of Health Systems: Switzerland, page 18
26

works, and for what the mandatory insurance covers. Switzerland has a very high number of
its citizens covered by health insurance as it is mandated. If the federal government would
alternate the insurance system so that starting at the most basic health insurance package all
vaccinations, including the measles vaccine, was completely covered this would help two
fold in the process. It would first ensure availability and accessibility to the measles vaccine
to the population and secondly it would help to show the position of the government in the
matter of measles vaccination.
Another important action the federal government can take is establishing a strong
position, and communicating this to the public.

Though the federal government in

Switzerland lacks the ability to develop and force implementation of a mandatory, or any
type, of measles vaccination program they still hold weight with the public. The federal
government must realize this power they hold in swaying the public’s opinion and
influencing their actions. The UK has already seen the weight that those in high government
positions can hold with the public. After the controversial research that related autism and
vaccination the public was very wary of vaccinated their children and felt that the
government’s silence on the issue was a sign that they too feared the possible effects of
vaccination, but once the link was disputed the then Prime Minister, Tony Blair, made clear
statements that he supported vaccinations and vaccinated his son.44 This communication –
through statements to the public and actions, by the government and government officials
were helpful in regaining the trust of the public in regards to vaccination and subsequently
raising vaccination rates, this too could be effective in Switzerland.
Looking to the cantonal level, where policy can be developed and implemented is at
the core of starting a successful mandatory measles vaccination program in Switzerland.
44
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Much like how the US developed the two-dose aspect of their vaccination policy, state by
state.45 While implementing a program on such a small scale would be frustrating as it is
harder to see the results, it would allow for perfection of implementation before wide spread
execution. Within Switzerland the canton of Vaud would be an ideal place to start the
implementation of a mandatory measles vaccine program. They already are a leader in
vaccination, as they are one of the few cantons that already have increasing vaccination
coverage as a priority in their health care agenda.46
The success in lowering measles incidence and the ease of running a mandatory
vaccination program would hopefully spread quickly to other cantons. Another reason that
the canton of Vaud is positioned well to be a leader in health care policy is that their
cantonal health minister, Pierre-Yves Maillard is also the head of the canton health ministers
and is in a position of power for the collective governance of the cantonal health ministers.
The most effective way to implement and then enforce a mandatory vaccination
program would be through the school system. This is an existing structure set up by the
government where large numbers of the population already move through.47 The age at
which an individual enters daycare or school is appropriate for when many vaccinations
should be delivered by, school records are already kept so adding vaccination would be
convenient and beyond record keeping, schools could be a place where vaccinations can be
distributed. While this system would add an extra strain on the school system, and give
them another responsibility, it is something the government can aid in, and should do so
willingly as it would be much more economically sound to add to an existing structure rather
than make a new one just for vaccination records and delivery.
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Much in the spirit of the incentive program set up in Australia using a similar
incentive program could be beneficial in building the individual benefits to a mandatory
measles vaccination program. While a straight payment for vaccination raises many more
ethical questions I believe implementing either a small reduction in daycare costs for those
who vaccinate their children, or a small sanction on those who do not vaccinate their
children would facilitate a more positive response from the public.
In respect to the publics opinion to a mandatory vaccination program it is also
important to have an open line of communication as to not alienate individuals who would
rebel over the fact of forcing medical interventions who would otherwise support the
measles vaccination. In this regard it seems essential to maintain an exemption policy.
While the exemption policy would allow for a certain part of the population to be
unvaccinated it seems much more realistic to be able to establish a successful mandatory
measles vaccination program with an exemption policy. The most common exemptions in
vaccination programs are; medical, religious and philosophical. These would also be in place
in a mandatory measles vaccination program, but more important than the types of
exemption is how exemptions would be carried out. As stated previously about 80% of the
population freely chooses to vaccinate without hesitation, 5% adamantly opposes
vaccination for religious or philosophical reasons and 15% of the population is neither for
nor against vaccination.48 This means that the 5% of the population who strongly opposes
measles vaccination will do whatever necessary to obtain an exemption where as the 15% of
the population that can be persuaded either way could either vaccinate or obtain an
exemption. It is important as a way to detract this population from choosing exemption to
make the exemption process a difficult and time-consuming process. It should take more
48
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time and effort to obtain an exemption than to vaccinate. This will help keep only those
who truly do object on religious, philosophical or medical basis to seek exemptions.
Next Steps
My investigation into the Swiss health system and the prospect of having a successful
mandatory measles vaccination program as a part of it was very limited to the French
speaking part of Switzerland. Switzerland is not only decentralized in its government, but
the country is also very different in its different sections. Before beginning any type of
mandatory vaccination program, even if only in the French speaking cantons, a further study
of a broader survey of the country would be essential. This is especially important in the
German speaking cantons
Another perspective that I was not able to gain as much insight into as I wished to is
that of the community and individual citizens. Having the viewpoint of the community
when creating a policy for them is very important and definitely warrants further study. As
with the other aspects of research, both in the geographic and medical senses, it is important
to discuss with a variety of sub populations from a variety of backgrounds.
The final aspect that would need to be evaluated extensively before any type of
policy could be truly recommended and then developed and implemented is the economic
aspect.

Though there is already research to support that the measles vaccine is cost

effective49, further research is needed specific to Switzerland and in a larger sense to assess
the economic costs of not only providing the measles vaccine, but implementing the proper
program support and education programs as well.
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Conclusion
After conducting a comprehensive review of the Swiss health care system, both the
contemporary and alternative medical perspectives on measles, and an evaluation of other
countries response to measles and their vaccination programs I was able to make an
educated evaluation of a mandatory measles vaccination program in Switzerland. Through
this evaluation I was able to come to the conclusion that based on my research a mandatory
program has a place in Switzerland. There were limitations to my study that warrant further
investigation before moving forward with a mandatory program.
Through my research I was able to make very relevant progress in my learning.
Primarily I was able to evaluate at a public health issue and then assess the health policy
options for the public health issue that ended in a policy recommendation. As I hope to
continue my education in health policy analysis and assessment this was a critical learning
process to experience. Another important outcome of my research was my utilization of
primary resources and emerging myself into the health care community of Geneva and
Vaud. Not only did my utilization of primary resources increase my knowledge of my topic
in a way that library research could never supplement, but it also boosted my confidence in
discussing my knowledge and ideas with others.
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